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Abstract SUNCT is a syndrome of short-lasting unilat-
eral neuralgiform headache attacks with conjunctival
injection and tearing. We are presenting now two cases
absolutely responders to steroid therapy, one of them a
SUNCT-like secondary to a prolactinoma and the other
primary.
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Introduction
SUNCT is a syndrome of short-lasting unilateral neural-
giform headache attacks with conjunctival injection and
tearing. It was first described in 1978 and fully character-
ized in 1989 [1, 2].
Suggested criteria for its diagnosis include attacks of
unilateral, moderately severe orbital or temporal stabbing
or throbbing pain lasting 5–240 s, with an attack frequency
of 3–200 per day and pain is associated with important
ipsilateral autonomic manifestations [3]. It is among the
rarest headache syndromes.
Several patients with secondary SUNCT syndromes
have been reported since 1991. They were associated with
cerebellopontine angle MAV, parapontine cavernous
angioma, dorsolateral brainstem infarction, HIV infection,
basilar impression, craniosynostosis, and hypophyseal
tumors [4].
Treatments—including methysergide, lithium, propan-
olol, amitriptyline, carbamazepine and prednisone—
usually have poor or negative results. Recently, some
partial improvements have been described with the use of
lamotrigine, gabapentin and topiramate [5–8].
We are presenting now two cases absolutely responders
to steroid therapy, one of them a SUNCT-like secondary to
a prolactinoma and the other primary.
Case 1
A 50-year-old male patient had his first pain attack 4 years
before admission. He described a daily severe pulsating pain
over the left supraorbital ridge and orbit, extended to the left
temple, associated with prominence of autonomic symptoms
such as lacrimation and conjunctival injection. Each indi-
vidual attack lasted 15–120 s and occurred three to six times
per day. Neck and head movements triggered pain attacks.
He was prescribed amitriptyline, indomethacin, topiramate,
and carbamazepine, which did not ameliorate his pain.
In between, he developed an ipsilateral shoulder pain
and was locally infiltered with steroids. After this proce-
dure he remained free of head pain for a month.
He had had a left IV nerve palsy 3 years before which
improved spontaneously. At this point neuroimaging was
not done because the patient did not accept it.
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On admission, clinical examination was unremarkable.
Verapamil was prescribed and the pain worsened both in
frequency and intensity as described [9]. The following
therapeutic choice was prednisone at a dose of 40 mg per
day with remission of pain in 24 h. Each time we tried to
stop the steroid treatment, recurrence of pain was observed.
Finally, a minimal dose 4 mg/day was sustained with
optimal results. The patient was recommended again to
have a neuroimaging study done and this time he accepted.
An MRI scan of the brain with and without gadolinium was
performed. The study revealed a pituitary adenoma also
extended to the left cavernous sinus wall (Fig. 1). No signs
or symptoms of the tumor were present. Visual field testing
was normal. Serum prolactin levels were markedly
elevated (1,853 ng/mL, normal range 0–20 ng/mL), but
testosterone, oestrogen, luteinizing hormone, follicle
stimulating hormone, thyroid stimulating hormone, free
thyroxin and growth hormone levels were normal. A
diagnosis of macroprolactinoma was made and treatment
with 2 mg/week of cabergoline was started. A month later
prednisone was stopped with no recurrence of headache.
Three months later prolactin serum levels were within
normal range (5 ng/mL) and a control MRI after a 6-month
follow-up showed a marked reduction of the neoplasm size
(Fig. 2). The patient has remained asymptomatic with
1 mg/week of cabergoline (prolactin 2.4 ng/mL) since
prolactinoma was diagnosed 7 months before.
Case 2
A 45-year-old male patient had experienced severe left
orbital side pulsating pain associated with tearing of the
ipsilateral eye and conjunctival injection for 2 months.
Potential triggers were strong smells.
Pain attacks lasted 30–90 s and occurred 20–50 times a
day. He had no past history of headache and did not recall
any trauma to his head. Clinical examination and brain
MRI were unremarkable.
SUNCT syndrome was diagnosed and therapeutic options
started. The response to indomethacin, lithium, carbamaze-
pine, amitriptyline, and ergotamine was frustrating.
Finally 40 mg/day prednisone was prescribed, and a
complete remission of pain was reached after 48 h.
Prednisone dose was decreased slowly until reaching
4 mg/day in 6 weeks. At a dose of 2 mg/day, the pain
recurred. For this reason, steroid has been maintained in
4 mg/day. The patient has remained asymptomatic since
the steroid drug was installed 15 months ago.
Discussion
Although SUNCT is a form of primary headache, symp-
tomatic cases have been reported [4]. The treatment of this
head pain has been very difficult and frustrating. Partial
response to several drugs has been published [5–8].
We are now reporting another two cases with similar
headache characteristics, and therapeutic response but with
different etiology. Table 1 shows a comparison of clinical
characteristics between both patients and IHS criteria.
Fig. 1 Macroprolactinoma invading left cavernous sinus at the
moment of diagnosis
Fig. 2 Reduction of the tumoral mass at 7 months of cabergoline
treatment
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In the first case (symptomatic), the transient left 4th
nerve palsy observed 3 years before, was not studied due to
the patient’s decision. Probably, the hypophyseal tumor
was already present.
When the headache started, different therapeutic drugs
were used with disappointing results. When a left shoulder
pain was present and a dexamethasone injection was pre-
scribed, the patient was free of head pain for several weeks.
Steroids (first used because of the patient’s omalgia and
then because of his headache) resolved the pain immedi-
ately and recurrence was observed each time they were
stopped.
As described previously, verapamil increased pain level.
Finally, the patient accepted to be studied and, through
laboratory tests and neuroimaging, a macroprolactinoma
was diagnosed. Specific treatment with cabergoline was
installed with remission of pain in accordance with the
reduction of tumor size and serum prolactin levels. Ca-
bergoline therapy allowed to suppress prednisone with no
recurrence of SUNCT symptoms.
We can justify the causal relationship considering:
1. Temporal relationship between the prolactinoma and
the onset of pain.
2. Side concordance: left cavernous sinus wall infiltration
and left side pain.
3. Prompt pain remission with specific therapy for the
tumor.
4. A 7-month follow-up.
If we considered that the suprasellar and left extension
of the tumor into the cavernous sinus might be responsible
for trigeminal activation leading to a homolateral SUNCT
syndrome, steroids benefits may be related to an anti-
inflammatory effect on both the tumor and the cavernous
sinus edema. The reduction of the pituitary mass by
specific drugs made the anti-inflammatory effect of steroids
unnecessary.
Considering that the pathophysiological mechanism of
primary SUNCT syndrome remains unknown, in the second
case presented, it is more difficult to find a rational expla-
nation to the mechanism of prednisone action. In spite of this,
some patients may benefit from prednisone treatment.
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Table 1 Comparative clinical findings
IHS criteria SUNCT Case 1: secondary SUNCT Case 2: primary SUNCT
Unilateral orbital, supraorbital or temporal
stabbing or pulsating pain lasting 5–240 s
Left supraorbital ridge, orbit and temple pain
lasting 15–120 s
Left orbital side pain lasting
30–90 s
Pain is accompanied by ipsilateral conjunctival
injection and lacrimation
Ipsilateral lacrimation and conjunctival injection Ipsilateral lacrimation and
conjunctival injection
Attacks occur with a frequency from 3 to 200 per
day
Three to six times a day 20–50 times a day
Not attributed to another disorder Hypophyseal tumor Normal neuroimaging
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